RGS Regis Corporation
$29.73▲ +0.00%
ConsumerDiscretionary
Other
Volume 236
Avg Volume (10D) 4.3K
Key Metrics & Fundamentals
Market Cap
$74.33M
P/E Ratio
12.3
Div Yield
0.00%
52W Range
0.00 - 30.93
% vs 50 MA
4.06%
% vs 200 MA
11.30%
RSI-14
56.1
MACD Histogram
-0.0200
Beta (1Y vs SPY)
0.53
Free Cash Flow
$3.60M
Gross Rev
$56.00M
Gross Profit
$21.76M
EBITDA
$8.43M
COGS
$34.24M
Operating Exp
$15.10M
Operating Income
$6.67M
EBIT
$6.67M
Pretax Income
$1.63M
Net Income
$4.40M
EPS (Diluted)
1.51
Price & Volume History
Loading chart…
Recent News
Regis (RGS) Reports $24.4M of Operating Income as Franchise Revenue Falls 12%. Can Company-Owned Salons Offset a Shrinking Franchise Base?
Insider Monkey · Sep 8, 2026 11:47 PM ET
104-year-old beauty chain closes hundreds of salons
TheStreet · Sep 7, 2026 12:07 PM ET
RGS Stock Rises Post Q4 Earnings Despite Revenue Slip, Supercuts Up Y/Y
Zacks · Sep 4, 2026 11:06 AM ET
Regis (RGS) Q4 2026 Earnings Call Transcript
Motley Fool · Sep 1, 2026 8:28 PM ET
Regis Corporation Q4 2026 Earnings Call Summary
Moby · Sep 1, 2026 4:50 PM ET
Regis Q4 Earnings Call Highlights
MarketBeat · Sep 1, 2026 10:03 AM ET
Regis Corporation Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year 2026
Business Wire · Sep 1, 2026 6:30 AM ET
Regis: Fiscal Q4 Earnings Snapshot
Associated Press · Sep 1, 2026 6:14 AM ET
Regis to Issue Fourth Quarter and Full Year 2026 Results on September 1, 2026
Business Wire · Aug 18, 2026 4:35 PM ET
Supercuts Partners With Jackson Olson to Debut 'The Jax' at Salons Nationwide
PR Newswire · Aug 6, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See RGS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.